Novel adjunctive treatments of myocardial infarction

Abstract

Myocardial infarction is a major cause of death and disability worldwide and myocardial infarct size is a major determinant of prognosis. Early and successful restoration of myocardial reperfusion following an ischemic event is the most effective strategy to reduce final infarct size and improve clinical outcome, but reperfusion may induce further myocardial damage itself. Development of adjunctive therapies to limit myocardial reperfusion injury beyond opening of the coronary artery gains increasing attention. A vast number of experimental studies have shown cardioprotective effects of ischemic and pharmacological conditioning, but despite decades of research, the translation into clinical effects has been challenging. Recently published clinical studies, however, prompt optimism as novel techniques allow for improved clinical applicability. Cyclosporine A, the GLP-1 analogue exenatide and rapid cooling by endovascular infusion of cold saline all reduce infarct size and may confer clinical benefit for patients admitted with acute myocardial infarcts. Equally promising, three follow-up studies of the effect of remote ischemic conditioning (RIC) show clinical prognostic benefit in patients undergoing coronary surgery and percutaneous coronary intervention. The discovery that RIC can be performed noninvasively using a blood pressure cuff on the upper arm to induce brief episodes of limb ischemia and reperfusion has facilitated the translation of RIC into the clinical arena. This review focus on novel advances in adjunctive therapies in relation to acute and elective coronary procedures.© 2014 Baishideng Publishing Group Inc. All rights reserved.Key words: Myocardial infarction; Primary percutaneous intervention; Coronary artery by-pass graft; Ischemiareperfusion injury; Ischemic preconditioning; Remote ischemic conditioning; Cyclosporine; Cooling; Exenatide Core tip: Patients with ischemic heart disease have a high risk of developing myocardial infarction, which is associated with considerable morbidity and mortality. Limiting the detrimental consequences of myocardial infarction is a major focus of cardiovascular research. Recent clinical studies suggest that novel adjunctive therapy with pharmacological and ischemic conditioning reduce ischemia-reperfusion injury in patients during coronary procedures. In three independent randomized trials, remote ischemic conditioning (RIC) improves clinical outcome in patients undergoing acute or elective percutaneous intervention or coronary artery bypass surgery. RIC can be performed safely and noninvasively by intermittent inflation of a blood-pressure cuff on the upper arm and is easily applicable in most clinical settings. worldwide [1,2] . Since 1990, more people have died from coronary artery disease than any other death cause [3,4] . In China, a staggering 230 million are estimated to suffer from cardiovascular disease, and three million Chinese die of cardiovascular disease annually, accounting for 41% of all deaths [5,6] . In the United States alone, cardiov...

Obstructive sleep apnea and adverse outcomes in surgical and nonsurgical patients on the wards

“…Ischemic preconditioning has been demonstrated in models of cardiac and neural tissue and has been shown to enhance stem cell survival by providing resistance to necrosis and lending functional benefits to heart, brain, and kidney models after transplantation . The fundamentals of this concept may have applications in transplant and cardiac surgery, in the management of acute coronary syndromes and stroke, and in athletic training and performance . Although OSA has been associated with long‐term cardiovascular morbidity and mortality, the intermittent hypoxemia OSA patients experience could actually improve their ability to survive clinical deterioration in the short‐term (ie, during a hospitalization).…”

Remote Ischemic Perconditioning to Reduce Reperfusion Injury During Acute ST‐Segment–Elevation Myocardial Infarction: A Systematic Review and Meta‐Analysis

“…Remote ischemic conditioning (RIC) is a noninvasive therapeutic strategy that uses brief cycles of blood pressure cuff inflation and deflation to protect the myocardium against ischemia–reperfusion injury . Previous proof‐of‐concept clinical studies using RIC before (preconditioning) or during (perconditioning) a major ischemic event have demonstrated improvements in surrogate markers of ischemia (eg, increased myocardial salvage and reduced infarct size) in a variety of clinical scenarios including acute STEMI, elective PCI, and coronary artery bypass grafting (CABG) surgery . In addition, in patients with STEMI, RIC before PCI has been shown to reduce the incidence of contrast‐induced acute kidney injury and has prevented acute kidney injury in patients undergoing cardiopulmonary bypass–assisted cardiac surgery …”

Trimetazidine Protects Umbilical Cord Mesenchymal Stem Cells Against Hypoxia and Serum Deprivation Induced Apoptosis by Activation of Akt

“…Despite the progress of medicine and therapeutic strategies, ischemic cardiovascular disease, which is associated with progressive heart failure, arrhythmias and sudden death, remains the most life-threatening health problem worldwide [1,2]. The potential severity to patients emphasizes the importance of novel and effective therapeutic strategies for ischemia cardiomyopathy.…”